These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8883014)

  • 21. Biocompatible membranes in acute renal failure: prospective case-controlled study.
    Schiffl H; Lang SM; König A; Strasser T; Haider MC; Held E
    Lancet; 1994 Aug; 344(8922):570-2. PubMed ID: 7914959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
    Szepietowski T; Krajewska M
    Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of three haemodialysis membranes on vancomycin disposition.
    Alwakeel J; Najjar TA; al-Yamani MJ; Huraib S; al-Haider A; Abu-aisha H
    Int Urol Nephrol; 1994; 26(2):223-8. PubMed ID: 8034435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of protein adsorption on haemodialysis-induced complement activation and neutrophil defects.
    Neveceral P; Markert M; Wauters JP
    Nephrol Dial Transplant; 1995; 10(3):372-6. PubMed ID: 7792033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of leukotriene B4 formation by dialyzer membranes.
    Schiffl H; Strasser T
    Biomater Artif Cells Artif Organs; 1990; 18(5):585-90. PubMed ID: 1965950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eicosanoid release in the endotoxin-primed isolated perfused rat lung and its pharmacological modification.
    Amann R; Schuligoi R; Peskar BA
    Inflamm Res; 1999 Dec; 48(12):632-6. PubMed ID: 10669114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choice of dialysis membrane does not influence the outcome of residual renal function in haemodialysis patients.
    Caramelo C; Alcázar R; Gallar P; Teruel JL; Velo M; Ortega O; Galera A; Da Silva M
    Nephrol Dial Transplant; 1994; 9(6):675-7. PubMed ID: 7970095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal keratoconjunctivitis.
    Akman A; Irkeç M; Orhan M
    Eye (Lond); 1998; 12 ( Pt 2)():291-5. PubMed ID: 9683957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of PAF and leukotrienes in bioincompatibility of cuprophane membranes in hemodialysis.
    Kabasakal C; Mir S; Gousseinov A; Cura A; Betin N; Coker I
    Turk J Pediatr; 1998; 40(3):413-20. PubMed ID: 9763906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arachidonic acid metabolites as biocompatibility parameters for cellulosic membranes.
    Boran M; Bozdayi M; Cetin S
    Nephrol Dial Transplant; 1999 Jul; 14(7):1804-5. PubMed ID: 10435906
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of leukotriene C4 and B4 release by human eosinophils with the new 5-lipoxygenase inhibitor 6-hydroxy-2(4-sulfamoylbenzylamino)-4,5,7-trimethylbenzothiazo le hydrochloride.
    Fukuda T; Numao T; Akutsu I; Toda M; Motojima S; Makino S
    Arzneimittelforschung; 1995 Sep; 45(9):1002-4. PubMed ID: 7488299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin 8 and biocompatibility of dialysis membranes.
    Niwa T; Miyazaki T; Sato M; Kambe F; Tsuzuki T; Uema K; Maeda K; Seo H
    Am J Nephrol; 1995; 15(3):181-5. PubMed ID: 7618641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukotriene B4 is involved in hemodialysis-associated neutropenia.
    Strasser T; Schiffl H
    Biochim Biophys Acta; 1990 Oct; 1046(3):326-9. PubMed ID: 2171673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of cyclooxygenase and lipoxygenase metabolites of arachidonic acid after transient cerebral ischemia.
    Dempsey RJ; Roy MW; Meyer K; Cowen DE; Tai HH
    J Neurosurg; 1986 Jan; 64(1):118-24. PubMed ID: 3001248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukocytes, eosinophils and complement function during hemodialysis with polysulphone and polymethylmethacrylate membranes: comparison with cuprophan and polyacrylonitrile.
    Bergesio F; Monzani G; Manescalchi F; Boccabianca I; Passaleva A; Frizzi V
    Blood Purif; 1988; 6(1):16-26. PubMed ID: 3345242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual stimulation of phospholipase activity in human monocytes. Role of calcium-dependent and calcium-independent pathways in arachidonic acid release and eicosanoid formation.
    Hoffman T; Lizzio EF; Suissa J; Rotrosen D; Sullivan JA; Mandell GL; Bonvini E
    J Immunol; 1988 Jun; 140(11):3912-8. PubMed ID: 2836505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells.
    Heavey DJ; Ernst PB; Stevens RL; Befus AD; Bienenstock J; Austen KF
    J Immunol; 1988 Mar; 140(6):1953-7. PubMed ID: 2450136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement activation and neutrophil aggregation changes during haemodialysis.
    Kubatiev A; Rudko I; Ermolenko V
    Int J Clin Pharmacol Res; 1993; 13(6):293-9. PubMed ID: 8088929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemodialyser biocompatibility and erythrocyte structure and function.
    Martos MR; Hendry BM; Rodríguez-Puyol M; Dwight J; Díez-Marqués ML; Rodríguez-Puyol D
    Clin Chim Acta; 1997 Sep; 265(2):235-46. PubMed ID: 9385465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.